SCOPUS 정보 검색 플랫폼

Volumn 11, Issue 6, 2005, Pages 349-352

Clinical traits of LRRK2-associated Parkinson's disease in Ireland: A link between familial and idiopathic PD

(14) Gosal, David a,b Ross, Owen A c,d Wiley, Joe a Irvine, G Brent c Johnston, Janet A c Toft, Mathias d Mata, Ignacio F d Kachergus, Jennifer d Hulihan, Mary d Taylor, Julie P d Lincoln, Sarah J d Farrer, Matthew J d Lynch, Timothy a,b Gibson, J Mark e

a MATER MISERICORDIAE UNIVERSITY HOSPITAL (Ireland)

b UNIVERSITY COLLEGE DUBLIN (Ireland)

c QUEEN'S UNIVERSITY BELFAST (United Kingdom)

d MAYO GRADUATE SCHOOL (United States)

e ROYAL VICTORIA HOSPITAL (United Kingdom)

Author keywords

G2019S and Parkinson's disease; LRRK2

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE IDENTIFICATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

EID: 24944533000 PISSN: 13538020 EISSN: None Source Type: Journal
DOI: 10.1016/j.parkreldis.2005.05.004 Document Type: Article

Times cited : (33)

References (13)

1
- 8844266996
- Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
- C. Paisan-Ruiz, S. Jain, E.W. Evans, W.P. Gilks, J. Simon, M. van der Brug, A.L. de Munain, S. Aparicio, A.M. Gil, N. Khan, J. Johnson, J.R. Martinez, D. Nicholl, I.M. Carrera, A.S. Pena, R. de Silva, A. Lees, J.F. Marti-Masso, J. Perez-Tur, N.W. Wood, and A.B. Singleton Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease Neuron 44 2004 595 600
- (2004) Neuron , vol.44 , pp. 595-600
- Paisan-Ruiz, C.¹ Jain, S.² Evans, E.W.³ Gilks, W.P.⁴ Simon, J.⁵ Van Der Brug, M.⁶ De Munain, A.L.⁷ Aparicio, S.⁸ Gil, A.M.⁹ Khan, N.¹⁰ Johnson, J.¹¹ Martinez, J.R.¹² Nicholl, D.¹³ Carrera, I.M.¹⁴ Pena, A.S.¹⁵ De Silva, R.¹⁶ Lees, A.¹⁷ Marti-Masso, J.F.¹⁸ Perez-Tur, J.¹⁹ Wood, N.W.²⁰ Singleton, A.B.²¹ more..

2
- 8844233579
- Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology
- A. Zimprich, S. Biskup, P. Leitner, P. Lichtner, M. Farrer, S. Lincoln, J. Kachergus, M. Hulihan, R.J. Uitti, D.B. Calne, A.J. Stoessl, R.F. Pfeiffer, N. Patenge, I.C. Carbajal, P. Vieregge, F. Asmus, B. Muller-Myhsok, D.W. Dickson, T. Meitinger, T.M. Strom, Z.K. Wszolek, and T. Gasser Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 2004 601 607
- (2004) Neuron , vol.44 , pp. 601-607
- Zimprich, A.¹ Biskup, S.² Leitner, P.³ Lichtner, P.⁴ Farrer, M.⁵ Lincoln, S.⁶ Kachergus, J.⁷ Hulihan, M.⁸ Uitti, R.J.⁹ Calne, D.B.¹⁰ Stoessl, A.J.¹¹ Pfeiffer, R.F.¹² Patenge, N.¹³ Carbajal, I.C.¹⁴ Vieregge, P.¹⁵ Asmus, F.¹⁶ Muller-Myhsok, B.¹⁷ Dickson, D.W.¹⁸ Meitinger, T.¹⁹ Strom, T.M.²⁰ Wszolek, Z.K.²¹ Gasser, T.²² more..

3
- 0032937059
- Diagnostic criteria for Parkinson disease
- D.J. Gelb, E. Oliver, and S. Gilman Diagnostic criteria for Parkinson disease Arch Neurol 56 1 1999 33 39
- (1999) Arch Neurol , vol.56 , Issue.1 , pp. 33-39
- Gelb, D.J.¹ Oliver, E.² Gilman, S.³

4
- 20144387207
- Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism; evidence for a common founder across European populations
- in press;
- Kachergus J, Mata IF, Hulihan M, Taylor JP, Lincoln S, Aasly J, Gibson JM, Ross OA, Lynch T, Wiley J, Payami H, Nutt J, Maraganore DM, Czyzewski K, Styczynska M, Wszolek ZK, Farrer MJ, Toft M. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism; evidence for a common founder across European populations. Am J Hum Genet in press;76.
- Am J Hum Genet , pp. 76
- Kachergus, J.¹ Mata, I.F.² Hulihan, M.³ Taylor, J.P.⁴ Lincoln, S.⁵ Aasly, J.⁶ Gibson, J.M.⁷ Ross, O.A.⁸ Lynch, T.⁹ Wiley, J.¹⁰ Payami, H.¹¹ Nutt, J.¹² Maraganore, D.M.¹³ Czyzewski, K.¹⁴ Styczynska, M.¹⁵ Wszolek, Z.K.¹⁶ Farrer, M.J.¹⁷ Toft, M.¹⁸

5
- 9144261126
- The PARK8 locus in autosomal dominant parkinsonism: Confirmation of linkage and further delineation of the disease-containing interval
- A. Zimprich, B. Muller-Myhsok, M. Farrer, P. Leitner, M. Sharma, M. Hulihan, P. Lockhart, A. Strongosky, J. Kachergus, D.B. Calne, J. Stoessl, R.J. Uitti, R.F. Pfeiffer, C. Trenkwalder, N. Homann, E. Ott, K. Wenzel, F. Asmus, J. Hardy, Z. Wszolek, and T. Gasser The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval Am J Hum Genet 74 2004 11 19
- (2004) Am J Hum Genet , vol.74 , pp. 11-19
- Zimprich, A.¹ Muller-Myhsok, B.² Farrer, M.³ Leitner, P.⁴ Sharma, M.⁵ Hulihan, M.⁶ Lockhart, P.⁷ Strongosky, A.⁸ Kachergus, J.⁹ Calne, D.B.¹⁰ Stoessl, J.¹¹ Uitti, R.J.¹² Pfeiffer, R.F.¹³ Trenkwalder, C.¹⁴ Homann, N.¹⁵ Ott, E.¹⁶ Wenzel, K.¹⁷ Asmus, F.¹⁸ Hardy, J.¹⁹ Wszolek, Z.²⁰ Gasser, T.²¹ more..

6
- 19944431081
- Network atIPG: A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease
- A. DiFonzo, C.F. Rohe, J. Ferreira, H.F. Chien, L. Vacca, F. Stocchi, L. Guedes, E. Fabrizio, M. Manfredi, N. Vanacore, S. Goldwurm, G. Breedveld, C. Sampaio, G. Meco, E. Barbosa, B.A. Oostra, and V. Bonifati Network atIPG: a frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease Lancet 365 2005 412 415
- (2005) Lancet , vol.365 , pp. 412-415
- Difonzo, A.¹ Rohe, C.F.² Ferreira, J.³ Chien, H.F.⁴ Vacca, L.⁵ Stocchi, F.⁶ Guedes, L.⁷ Fabrizio, E.⁸ Manfredi, M.⁹ Vanacore, N.¹⁰ Goldwurm, S.¹¹ Breedveld, G.¹² Sampaio, C.¹³ Meco, G.¹⁴ Barbosa, E.¹⁵ Oostra, B.A.¹⁶ Bonifati, V.¹⁷

7
- 19944432921
- A common LRRK2 mutation in idiopathic Parkinson's disease
- W.P. Gilks, P.M. Abou-Sleiman, S. Gandhi, S. Jain, A. Singleton, A.J. Lees, K. Shaw, K.P. Bhatia, V. Bonifati, N.P. Quinn, J. Lynch, D.G. Healy, J.L. Holton, T. Revesz, and N.W. Wood A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 2005 415 416
- (2005) Lancet , vol.365 , pp. 415-416
- Gilks, W.P.¹ Abou-Sleiman, P.M.² Gandhi, S.³ Jain, S.⁴ Singleton, A.⁵ Lees, A.J.⁶ Shaw, K.⁷ Bhatia, K.P.⁸ Bonifati, V.⁹ Quinn, N.P.¹⁰ Lynch, J.¹¹ Healy, D.G.¹² Holton, J.L.¹³ Revesz, T.¹⁴ Wood, N.W.¹⁵

8
- 19944432606
- Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease
- W.C. Nichols, N. Pankratz, D. Hernandez, C. Paisan-Ruiz, S. Jain, C.A. Halter, V.E. Michaels, T. Reed, A. Rudolph, C.W. Shults, A. Singleton, and T. Foroud Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease Lancet 365 2005 410 412
- (2005) Lancet , vol.365 , pp. 410-412
- Nichols, W.C.¹ Pankratz, N.² Hernandez, D.³ Paisan-Ruiz, C.⁴ Jain, S.⁵ Halter, C.A.⁶ Michaels, V.E.⁷ Reed, T.⁸ Rudolph, A.⁹ Shults, C.W.¹⁰ Singleton, A.¹¹ Foroud, T.¹²

9
- 0036196860
- A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
- M. Funayama, K. Hasegawa, H. Kowa, M. Saito, S. Tsuji, and F. Obata A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1 Ann Neurol 51 2002 296 301
- (2002) Ann Neurol , vol.51 , pp. 296-301
- Funayama, M.¹ Hasegawa, K.² Kowa, H.³ Saito, M.⁴ Tsuji, S.⁵ Obata, F.⁶

10
- 20444420103
- An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
- Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 2005; 57(6): 918-21.
- (2005) Ann Neurol , vol.57 , Issue.6 , pp. 918-921
- Funayama, M.¹ Hasegawa, K.² Ohta, E.³ Kawashima, N.⁴ Komiyama, M.⁵ Kowa, H.⁶ Tsuji, S.⁷ Obata, F.⁸

11
- 12144290127
- +-induced neurotoxicity in SH-SY5Y cells
- +-induced neurotoxicity in SH-SY5Y cells Brain Res 1003 2004 86 97
- (2004) Brain Res , vol.1003 , pp. 86-97
- Mathiasen, J.R.¹ McKenna, B.A.W.² Saporita, M.S.³ Ghadge, G.D.⁴ Roos, R.P.⁵ Holskin, B.P.⁶ Wu, Z.L.⁷ Trusko, S.P.⁸ Connors, T.C.⁹ Maroney, A.C.¹⁰ Thomas, B.A.¹¹ Thomas, J.C.¹² Bozyczko-Coyne, D.¹³

12
- 0033029823
- An inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo
- M.S. Saporita, E.M. Brown, M.S. Miller, and S. Carswell An inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo J Pharmacol Exp Ther 288 1999 421 427
- (1999) J Pharmacol Exp Ther , vol.288 , pp. 421-427
- Saporita, M.S.¹ Brown, E.M.² Miller, M.S.³ Carswell, S.⁴

13
- 1342344813
- Mixed-lineage kinases: A target for the prevention of neurodegeneration
- L.H. Wang, C.G. Besirli, and E.M. Johnson Jr Mixed-lineage kinases: a target for the prevention of neurodegeneration Annu Rev Pharmacol Toxicol 44 2004 451 474
- (2004) Annu Rev Pharmacol Toxicol , vol.44 , pp. 451-474
- Wang, L.H.¹ Besirli, C.G.² Johnson Jr., E.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.